Mualliflar

  • Umurov N.A., Abdullajanova Sh.J.

##semicolon##

COVID-19, pneumonia, anxiety, depression, predictors, risk factors, comorbidity, regression, mental health

##submission.citations##

Lei L, Huang X, Zhang S, et al. Comparison of prevalence and associated factors of anxiety and depression among people affected by COVID-19 and those not affected by quarantine during the COVID-19 epidemic in Southwest China. Med Sci Monit 2020;26:e924609.

Temporary methodological recommendations "Prevention, diagnosis and treatment of the new coronavirus infection (COVID-19)." Version 9 (26.10.2020). Ministry of Health of the Russian Federation, p. 227.

Artemyeva M. S. Variants of Psychoorganic Syndrome in Alcoholism (Features of Clinic and Dynamics): monograph. - Kaliningrad: Publishing House of the Baltic Federal University named after Immanuel Kant, 2015. - 117 p.

Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 2020; 11:995-8.

Baturin K.A., Vishnevskaya O.V. Psychosomatic Relationships in Patients with Bronchial Asthma.// In the collection: Materials of the Conference of Young Psychiatrists of the State Scientific Center of the Ministry of Health of the Russian Federation named after V.P. Serbsky "Mental Health of the Population of Russia" (theses of reports) 2001. P. 24.

Bronchial asthma with hyperventilation syndrome (psychosomatic features) // In the collection: Materials of the 10th National Congress on Diseases of the Respiratory Organs (theses of reports) SPb, 2001. P. 58.

Daly JL, Simonetti B, Klein K, et al. Neuropilin-1 is a host factor for SARSCoV-2 infection. Science 2020;370 (6518):861-5.

Drobizhev M.Yu, Ovcharenko S.I., Ishchenko E.N., Baturin K.A., Vishnevskaya O.V. Anxiety-phobic disorders in patients with respiratory disorders.// Journal of Neurology and Psychiatry named after S.S. Korsakov, - 2001., volume 101, No 5, - pp.12-16.

Drobizhev M.Yu, Ovcharenko S.I., Ishchenko E.N., Vishnevskaya O.V., Baturin K.A., Tokareva N.A. Paroxetine in the treatment of depressive and anxiety-phobic conditions in patients with bronchial asthma.// Pulmonology 2002. - No2. - pp. 96-100.

Evans J.P., Liu S.L. The role of host factors in SARS-CoV-2 entry. J Biol Chem 2021;297 (1):100847.

Hamming I, Timens W, Bulthuis ML, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding the pathogenesis of SARS. J Pathol 2004; 203:631-7.

Holmes E.A., O'Connor R.C., Perry V.H., et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry 2020; 7:547-60.

Ischenko E.N., Ovcharenko S.L., Drobizhev M.Yu., Smulevich A.B., Visnevskaya O.V., Baturin K.A., Tokareva N.A. Bronchial asthma and hyperventilation.// In abstracts of 11ERS Annual Congress, Berlin Sept. Europe. Resp. J., 2001. Vol. 18, suppl. 33, 52p., p. 22-26

Korkina, M. V. Mental Disorders in Somatic Diseases / M. V. Korkina, V. V. Marilov, M. S. Artemyeva et al. // Psychiatry Practicum / edited by M. V. Korkina. Moscow: RUDN, 2014. - 306 p.

Mao L, Jin H, Wang M, et al. Neurological manifestations of patients hospitalized with Coronavirus in Wuhan, China. JJAMA Neurol 2020;77 (6):683-90.

Ovcharenko S.I., Drobizhev M.Yu, Ishchenko E.N., Vishnevskaya O.V., Baturin K.A., Tokareva N.A. Bronchial asthma with hyperventilation.// Pulmonology - 2001. - No. 4. - P. 36-41.

Ovcharenko S.I., Ishchenko E.N., Drobizhev M.Yu., Vishnevskaya O.V., Baturin K.A., Tokareva N.A. Bronchial asthma with hyperventilation syndrome - clinical variant or stage of disease progression?// Pulmonology Appendix to the summary of the theses of the 11th National Congress on Diseases of the Respiratory System 2001. - P. 47.

Pfefferbaum B, North CS. Mental health and the Covid-19 pandemic. N Engl J Med 2020 383 (6):510-2.

Smulevich A.B., Drobizhev M.Yu., Ovcharenko S.I., Ishchenko E.N., Vishnevskaya O.V., Baturin K.A. Psychopharmacology of hyperventilation syndrome in patients with bronchial asthma (experiment with the use of thianeptine).// In the collection: Materials of the 8th Russian Congress "Man and Medicine" 2001.

Smulevich A.B., Ovcharenko S.I., Drobizhev M.Yu, Ishchenko E.N., Baturin K.A. Vishnevskaya O.V. Experience of using thianeptine in hyperventilation syndrome in patients with bronchial asthma.// "Clinical Pharmacology and Therapy" - 2001. - No. 40. - P. 5-7.

Smulevich A.B., Rappoport S.I., Syrkin A.L., Ovcharenko S.I., Ivanov S.A., Drobizhev M.Yu., Ishchenko E.N., Baturin K.A. Organskiye nevrozi: klinicheskiye aspekti problemi.// Journal of Neurology and Psychiatry named after S.S. Korsakov, 2002, vol. 102, N1, pp. 15-21.

Temporary methodological recommendations "Prevention, diagnosis and treatment of the new coronavirus infection (COVID-19)." Version 15 (22.02.2022).

Vishnevskaya O.V., Baturin K.A. Bronchial asthma with hyperventilation phenomena.// In the collection: Materials of the 11th Russian Conference of Young Scientists "Fundamental Sciences and Progress of Clinical Medicine" (theses of reports) - M. - 2001. - p. 148

Xia H, Lazartigues E. Angiotensin-converting enzyme 2 in the brain: properties and future directions. J. Neurochem. 2008. 107:1482-94.

Xiang YT, Yang Y, Li W, et al. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry. 2020; 7:228-9.